Potential Impact of Nirsevimab on RSV Transmission and Medically Attended Lower Respiratory Tract Illness Caused by RSV: A Disease Transmission Model

INTRODUCTION: Respiratory syncytial virus (RSV) is associated with significant morbidity worldwide, especially among infants. We evaluated the potential impact of prophylactic nirsevimab, a monoclonal antibody, in infants experiencing their first RSV season, and the number of medically-attended lowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Voirin, Nicolas, Virlogeux, Victor, Demont, Clarisse, Kieffer, Alexia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847469/
https://www.ncbi.nlm.nih.gov/pubmed/34813073
http://dx.doi.org/10.1007/s40121-021-00566-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847469/
https://www.ncbi.nlm.nih.gov/pubmed/34813073
http://dx.doi.org/10.1007/s40121-021-00566-9

Ejemplares similares